scispace - formally typeset
Journal ArticleDOI

Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.

TLDR
In this article, it was shown that cat arterial thromboembolism (ATE), an often devastating outcome, affects 11.3% of cats with hypertrophic cardiomyopathy over 10 years.
Abstract
ObjectivesFeline arterial thromboembolism (ATE), an often devastating outcome, was recently shown to affect 11.3% of cats with hypertrophic cardiomyopathy over 10 years. Current American College of...

read more

Citations
More filters
Journal ArticleDOI

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.

TL;DR: The most common form of feline cardiomyopathy observed clinically and may affect up to approximately 15% of the domestic cat population, according to as mentioned in this paper, which is the most common type of cat HCM.
Journal ArticleDOI

The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.

TL;DR: Although feline hypertrophic cardiomyopathy (HCM) occurs more commonly, dilated cardiomeopathy (DCM), restrictive cardiopathy (RCM), arrhythmogenic right ventricular cardiOME (RVCC) occur more commonly in cats.
Journal ArticleDOI

The Feline Cardiomyopathies: 1. General concepts.

TL;DR: The most common type of cat heart disease is hypertrophic cardiomyopathy (HCM) as discussed by the authors, which is the most prevalent type of heart disease in adult domestic cats.
Journal ArticleDOI

Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism

TL;DR: This study supports the intravenous use of enoxaparin in combination with oral clopidogrel for cats with thromboembolism as an alternative treatment method and reports similar discharge rates and lower hemorrhage rates than previously reported withThrombolytic treatment.
Journal ArticleDOI

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy

TL;DR: In this article , a prospective, randomized, controlled cross-over study was performed to evaluate pharmacodynamic effects of two doses (0.3 and 1 mg/kg) of a next-in-class cardiac myosin inhibitor, aficamten (CK-3773274, CK-274), on cardiac function in cats with the A31P MYBPC3 mutation and oHCM.
References
More filters
Journal ArticleDOI

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

TL;DR: Interindividual variability in the platelet inhibitory response from clopidogrel occurs in patients undergoing elective coronary stenting, and patients with high pretreatment reactivity are least protected.
Journal ArticleDOI

Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999)

TL;DR: Overall survival time for cats with HCM was similar to earlier reports, but survival times for Cats with CHF or ATE were longer than previously reported.
Journal ArticleDOI

Prevalence of cardiomyopathy in apparently healthy cats.

TL;DR: In apparently healthy cats, detection of a heart murmur is not a reliable indicator of cardiomyopathy, which was common in the healthy cats evaluated in this study.
Journal ArticleDOI

Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994–2001):

TL;DR: The case records of 106 cats with idiopathic cardiomyopathy that presented to the Feline Centre of the University of Bristol between September 1994 and September 2001 were reviewed retrospectively and a greater survival time was observed for cats with UCM when compared with those with HCM, RCM or DCM.
Journal ArticleDOI

Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study).

TL;DR: It is found thatpertrophic cardiomyopathy is common in apparently healthy cats, in contrast with otherCardiomyopathies, and heart murmurs are also common, and are often functional.
Related Papers (5)